0000909012-13-000139.txt : 20130221
0000909012-13-000139.hdr.sgml : 20130221
20130221120126
ACCESSION NUMBER: 0000909012-13-000139
CONFORMED SUBMISSION TYPE: 13F-HR/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121231
FILED AS OF DATE: 20130221
DATE AS OF CHANGE: 20130221
EFFECTIVENESS DATE: 20130221
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC
CENTRAL INDEX KEY: 0001224962
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-10438
FILM NUMBER: 13629410
BUSINESS ADDRESS:
STREET 1: 499 PARK AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-205-5340
MAIL ADDRESS:
STREET 1: 499 PARK AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR/A
1
t307073.txt
PERCEP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F-HR/A
Form 13F COVER PAGE
Report for the Calendar Year of Quarter Ended: December 31, 2012
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[X] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Perceptive Advisors LLC
Address: 499 Park Ave, 25th Floor
New York, NY 10022
Form 13F File Number: 28-10438
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Joseph Edelman
Title: Managing Member
Phone: (646) 205-5342
Signature, Place, and Date of Signing:
/s/ Joseph Edelman New York, NY February 21, 2013
[Signature] [City, State] [Date]
Report Type (Check only one.):
[ X ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 76
Form 13F Information Table Value Total: $570,244
(thousands)
List of Other Included Managers:
{None}
Title
of Value Shs or Sh/ Put/ Investment Other Voting Authority
Name of Issuer Class CUSIP (x1000) Prn Amt Prn Call Discretion Managers Sole Shared None
COVIDIEN PLC SHS G2554F113 7,593 131,500 SH 131,500
ABBVIE INC COM 00287Y109 683 20,000 SH 20,000
ACADIA PHARMACEUTICALS INC COM 4225108 1,860 400,000 SH 400,000
ACELRX PHARMACEUTICALS INC COM 00444T100 21,336 5,008,400 SH 5,008,400
AEGERION PHARMACEUTICALS INC COM 7.67E+104 66,375 2,615,293 SH 2,615,293
ALERE INC COM 01449J105 1,018 55,000 SH 55,000
AMARIN CORP PLC SPONS ADR NEW 23111206 405 50,000 Put 50,000
AMGEN INC COM 31162100 18,102 210,000 SH 210,000
ANTHERA PHARMACEUTICALS INC COM 03674U102 1,352 2,180,588 SH 2,180,588
ASTEX PHARMACEUTICALS INC COM 04624B103 1,252 430,100 SH 430,100
ATHERSYS INC COM 04744L106 4,724 4,456,797 SH 4,456,797
CAPITAL SR LIVING CORP COM 140475104 22,642 1,211,469 SH 1,211,469
CELL THERAPEUTICS INC COM NPV NEW 2012 150934883 359 276,100 SH 276,100
CELGENE CORP COM 151020104 8,239 105,000 SH 105,000
CELLDEX THERAPEUTICS INC NEW COM 15117B103 222 33,103 SH 33,103
CELSION CORPORATION COM NEW 15117N305 25,389 3,100,000 Put 3,100,000
CEMPRA INC COM 15130J109 2,880 450,000 SH 450,000
COMBIMATRIX CORPORATION *W EXP 05/01/201 20009T121 2 5,000 SH 5,000
CONCEPTUS INC COM 206016107 824 39,233 SH 39,233
CUTERA INC COM 232109108 4,004 444,881 SH 444,881
CYNOSURE INC CL A 232577205 482 20,000 SH 20,000
DARA BIOSCIENCES INC COM NEW 23703P205 578 750,000 SH 750,000
DYAX CORP COM 2.67E+107 3,172 911,457 SH 911,457
DYNAVAX TECHNOLOGIES CORP COM 268158102 1,140 400,000 Put 400,000
ENTEROMEDICS INC COM NEW 29365M208 14 5,000 SH 5,000
EXACT SCIENCES CORP COM 30063P105 5,401 510,000 Put 510,000
EXACT SCIENCES CORP COM 30063P105 1,165 110,000 Call 110,000
EXACT SCIENCES CORP COM 30063P105 424 40,000 SH 40,000
EXACT SCIENCES CORP COM 30063P105 7,477 706,000 SH 706,000
GENVEC INC COM NEW 37246C307 19 13,964 SH 13,964
GILEAD SCIENCES INC COM 375558103 10,511 143,100 SH 143,100
HCA HOLDINGS INC COM 40412C101 17,423 577,500 SH 577,500
INFINITY PHARMACEUTICALS INC COM 45665G303 89,066 2,544,739 SH 2,544,739
ISIS PHARMACEUTICALS INC COM 464330109 1,044 100,000 Put 100,000
KERYX BIOPHARMACEUTICALS INC COM 492515101 3,005 1,146,900 SH 1,146,900
LEXICON PHARMACEUTICALS INC COM 528872104 5,303 2,399,500 SH 2,399,500
MGC DIAGNOSTICS CORP COM 552768103 726 123,114 SH 123,114
MAKO SURGICAL CORP COM 560879108 2,249 175,000 SH 175,000
MAP PHARMACEUTICALS INC COM 56509R108 783 50,000 Put 50,000
MERCK & CO INC NEW COM 58933Y105 49 1,200 SH 1,200
MYLAN INC COM 628530107 1,373 50,000 Put 50,000
MYLAN INC COM 628530107 1,373 50,000 SH 50,000
NEOSTEM INC COM NEW 640650305 1,975 3,315,938 SH 3,315,938
NEPTUNE TECHNOLOGIES BIORESO COM 64077P108 11,307 5,622,920 SH 5,622,920
NEUROCRINE BIOSCIENCES INC COM 64125C109 30,609 4,092,137 SH 4,092,137
NOVARTIS A G SPONSORED ADR 66987V109 6,602 104,300 SH 104,300
OSI SYSTEMS INC COM 671044105 3,202 50,000 Put 50,000
ONCOTHYREON INC COM 682324108 380 197,700 Put 197,700
PACIFIC BIOSCIENCES CALIF IN COM 69404D108 128 75,000 SH 75,000
PHARMACYCLICS INC COM 716933106 3,467 60,000 SH 60,000
PROLOR BIOTECH INC COM 74344F106 6,363 1,285,544 SH 1,285,544
PROTALIX BIOTHERAPEUTICS INC COM 74365A101 1,848 356,049 SH 356,049
PUMA BIOTECHNOLOGY INC COM 74587V107 375 20,000 SH 20,000
QUESTCOR PHARMACEUTICALS INC COM 74835Y101 1,069 40,000 SH 40,000
RTI BIOLOGICS INC COM 74975N105 598 140,000 SH 140,000
REPROS THERAPEUTICS INC COM NEW 76028H209 45,085 2,862,560 SH 2,862,560
SAREPTA THERAPEUTICS INC COM 803607100 7,740 100,000 Call 100,000
SAREPTA THERAPEUTICS INC COM 803607100 13,416 50,000 Put 50,000
SAREPTA THERAPEUTICS INC COM 803607100 33,457 1,296,800 SH 1,296,800
SHIRE PLC SPONSORED ADR 82481R106 16,592 180,000 SH 180,000
SPECTRANETICS CORP COM 84760C107 223 15,100 SH 15,100
SPECTRUM PHARMACEUTICALS INC COM 84763A108 189 16,902 SH 16,902
STEMCELLS INC COM NEW 85857R204 378 231,600 SH 231,600
SUNESIS PHARMACEUTICALS INC COM NEW 867328601 210 50,000 SH 50,000
SUNRISE SENIOR LIVING INC COM 86768K106 1,048 72,900 SH 72,900
SUPERNUS PHARMACEUTICALS INC COM 868459108 3,944 550,000 SH 550,000
SYNTA PHARMACEUTICALS CORP COM 87162T206 8,959 993,236 SH 993,236
TEKMIRA PHARMACEUTICALS CORP COM NEW 87911B209 1,602 320,000 SH 320,000
TRANSGENOMIC INC RSTD COM 89365K206 1,159 1,900,000 SH 1,900,000
TENET HEALTHCARE CORP COM NEW 88033G407 5,520 170,000 SH 170,000
TRINITY BIOTECH PLC SPON ADR NEW 896438306 3 200 SH 200
UROPLASTY INC COM NEW 917277204 2,253 693,143 SH 693,143
VERASTEM INC COM 92337C104 104 11,818 SH 11,818
VIROPHARMA INC COM 928241108 15,620 686,300 SH 686,300
XOMA CORP DEL COM 98419J107 701 292,250 SH 292,250
ZIOPHARM ONCOLOGY INC COM 98973P101 2,080 500,000 Put 500,000
570,244